Akgonul Rifat Kerim 4
4 · PEGASYSTEMS INC · Filed Mar 13, 2026
Research Summary
AI-generated summary of this filing
PEGA CPO Rifat Kerim Exercises Options and Sells Shares
What Happened
- Rifat Kerim Akgonul, Chief Product Officer at Pegasystems (PEGA), exercised options and disposed of shares on 2026-03-11. The filing shows an exercise of 30,000 options at $23.64 per share (cost $709,200). To cover taxes and related liabilities, 21,912 shares were withheld/disposed at $43.49 ($952,953). An additional 8,088 shares were sold in the open market at $43.56 ($352,354). The filing also records a 30,000-share derivative conversion (listed at $0), reflecting the option-to-share conversion. Total gross proceeds from the share disposals reported: $952,953 + $352,354 = $1,305,307; exercise cost reported: $709,200.
Key Details
- Transaction date: 2026-03-11.
- Exercise: 30,000 shares at $23.64 = $709,200 (code M).
- Tax withholding/disposition: 21,912 shares at $43.49 = $952,953 (code F).
- Open-market sale: 8,088 shares at $43.56 = $352,354 (code S).
- Derivative conversion: 30,000 shares reported disposed at $0 (reflects conversion from options).
- Footnote: the option exercised is fully vested (F1).
- Shares owned after the transaction: not specified in the filing.
- Filing timeliness: Form 4 filed 2026-03-13 for 2026-03-11 transactions — appears timely (within the standard 2-business-day window).
Context
- This was an option exercise with shares withheld for taxes and a small open-market sale — a common cashless/covering transaction rather than a straightforward buy signal. Transaction codes: M = exercise of derivative/option, F = tax withholding, S = sale. The exercise plus share disposals report realized gross proceeds of about $1.305M and an exercise cost of $709,200 (net ~ $596K before fees and any other taxes).
Insider Transaction Report
Form 4
PEGASYSTEMS INCPEGA
Akgonul Rifat Kerim
Chief Product Officer
Transactions
- Exercise/Conversion
Common stock
2026-03-11$23.64/sh+30,000$709,200→ 141,429 total - Tax Payment
Common stock
2026-03-11$43.49/sh−21,912$952,953→ 119,517 total - Sale
Common stock
2026-03-11$43.56/sh−8,088$352,354→ 111,429 total - Exercise/Conversion
Stock Options
[F1]2026-03-11−30,000→ 30,000 totalExercise: $23.64From: 2025-03-07Exp: 2033-03-07→ Common stock (30,000 underlying)
Footnotes (1)
- [F1]This option is fully vested.
Signature
/s/ Ewelina Kemp, Attorney-in-Fact for Rifat Kerim Akgonul|2026-03-13